Daniel Jay Brat
Northwestern University
Public scientific profile · Unclaimed
Built from public scholarly sources. Expertise is inferred by ScienceWe from publications and has not been confirmed by the scientist.
Top expertise
Glioma Diagnosis and Treatment
Strong evidence · 10 supporting papers · latest 2026
Meningioma and schwannoma management
Strong evidence · 3 supporting papers · latest 2026
Brain Metastases and Treatment
Solid evidence · 5 supporting papers · latest 2026
Cell death mechanisms and regulation
Solid evidence · 1 supporting paper · latest 2025
interferon and immune responses
Solid evidence · 1 supporting paper · latest 2025
Hippo pathway signaling and YAP/TAZ
Solid evidence · 1 supporting paper · latest 2025
AI in cancer detection
Solid evidence · 1 supporting paper · latest 2026
Advanced Breast Cancer Therapies
Solid evidence · 2 supporting papers · latest 2026
Publications (15)
cIMPACT-NOW Update 12: Refining pathology-based risk stratification and grading for IDH-mutant gliomas
2026DOIPMID 42152226
Development, validation, and utility of a clinically applicable methylation classifier for recurrence risk prediction in meningiomas
2025DOIPMID 41466325
Targeting Survivin: Now I Become Death, the Destroyer of Cells
2025DOIPMID 41373575
2. Chromothripsis in meningiomas is associated with more aggressive behavior
2025DOI
IMMU-07. Synergistic STING activation in meningioma neoplastic and immune populations triggers programmed necrosis and modulates the collagen-rich immunosuppressive microenvironment
2025DOI
Recommendations in cIMPACT-NOW Update 12 should identify grade 2 IDH-mutant astrocytoma patients with truly low-risk disease by pathology
2026DOIPMID 42696408
Epidemiology of primary brain and other central nervous system tumors for practicing healthcare providers in neuro-oncology, CBTRUS 2018-2022
2026DOI
TMIC-95. Hypoxic Tumor Microenvironment Promotes Hippo Pathway Transcriptional Activity to Enrich Glioma Stem Cells in the Peri-necrotic Niche of Glioblastoma
2025DOI
Inferring DNA methylation class from digitized pathology images and artificial intelligence: A worthy and timely application with room for improved clinical performance
2026DOIPMID 42381295
Effects of combination therapy of a CDK4/6 and MEK inhibitor in diffuse midline glioma preclinical models
2025DOIPMID 41428766
Abstract 1150: Combining CDK4/6 inhibitor with TMZ and radiation alters cell states for synergistic responses in orthotopic DIPG models
2026DOI
TMIC-03. The Hypoxic Peri-necrotic Niche of Glioblastoma Drives TAM Polarization and Immunosuppression Through CLEC5A Activation by Podoplanin
2025DOI
CNSC-83. A CHARACTERIZATION OF QUIESCENCE AND STEMNESS IN PATIENT-DERIVED GLIOBLASTOMA CELLS
2025DOI
IMMU-29. CSMD3 modulates the inflammatory induction of diffusely infiltrating low-grade gliomas in preclinical models
2025DOI
Uncovering a feedback loop in glioblastoma that reinforces stemness and immunosuppression
2026DOIPMID 42138075
Organizations in sourced records
Affiliation evidence only — not confirmed current employment.
- Northwestern University
Source: OpenAlex · retrieved 2026-09-29